Public Health Agency of Canada
Symbol of the Government of Canada

Share this page

Medical Access to Artesunate or Quinine for Malaria Treatment Streamlined in Canada through the Canadian Malaria Network (CMN)

Malaria continues to be a major cause of death worldwide and is the principal life-threatening infection facing Canadian travellers in malaria-endemic areas. Severe P. falciparum malaria infections may have a mortality rate of 20% or higher. Patients require immediate hospitalization and urgent, intensive medical management, including parenteral malaria therapy. Severe malaria is not a common disease in Canada, with an average of 14 cases per year (range 8-20 cases annually from 2001-2008). However, these cases are dispersed across the country, and attest to the need for distribution of these scarce antimalarial drugs for treatment of severe malaria across the country.

Artesunate,the preferred medication for the treatment of severe and cerebral malaria due to P. falciparum, and quinine, a possible alternative when artesunate is contraindicated, are only available in Canada through Health Canada's Special Access ProgramThis link opens in a new browser window, a program that allows practitioners to request access to drugs that are unavailable for sale in Canada. Although quinidine is available and is equally efficacious in treating malaria, it has a risk of life-threatening cardiotoxicity and an associated requirement for cardiac monitoring.

The Canadian Malaria Network was created in collaboration with Health Canada's Special Access Program and the Public Health Agency of Canada due to the potential for adverse outcomes associated with delays in acquiring parenteral malaria therapy. The Canadian Malaria Network (CMN) is established in 11 medical centres across Canada and maintains and facilitates rapid access to strategically-located supplies of intravenous artesunate and quinine for the treatment of severe P. falciparum. In addition, each of the participating centers has a designated physician with experience in treating malaria who is willing to assist and provide guidance in the management of malaria infections. These life-saving drugs are available 24 hours per day by contacting the pharmacies listed below. After-hours assistance can be obtained by contacting the infectious disease consultant on call at the respective center. Each Centre provides surveillance data to Health Canada on all malaria cases treated with these drugs.

Once a request is made to any of the designated CMN centres for either parenteral artesunate or quinine, the attending physician will receive the following via courier delivery:

  • treatment dose
  • information on treatment and chemotherapy for severe falciparum malaria
  • forms to be completed for the collection of surveillance data (Forms A & B).

The attending physician will be asked to complete and send to the CMN National Coordinator the forms at the time of access/ request of intravenous artesuate or quinine (Form A) and at discharge/end of malaria therapy (Form B). The information collected on these forms is vital to inform policy for distribution of these drugs, and required by the organizations supplying these drugs for notification of any drug related adverse event. 

Note: Fever occurring in a traveller within three months of returning from a malaria-endemic area is a medical emergency and should be investigated urgently with thick and thin blood films for malaria.

back to top

Table 1: Criteria for Severe Falciparum Malaria 

EITHER
History of recent possible exposure and no other related pathology
OR
Asexual forms of Plasmodium falciparum on blood smear
AND
Any one or more of the following 11 features:

  1. impaired consciousness or coma 
  2. severe normocytic anemia 
  3. renal failure 
  4. pulmonary edema 
  5. hypoglycemia 
  6. circulatory collapse, shock 
  7. spontaneous bleeding / disseminated intravascular coagulation 
  8. repeated generalized convulsions 
  9. acidemia / acidosis 
  10. hemoglobinuria 
  11. parasitimia of > 5% in non-immune individuals

Adapted from: Severe and complicated malaria, 2nd ed. Trans Roy Soc Trop Med Hyg 1990;84(Suppl 2).  

back to top

Contact Information

The following hospital Centers across Canada have been identified as participants in the Canadian Malaria Network (CMN ).

To obtain artesunate or quinine, please contact the listed pharmacy in your area. The designated physician for each Center can be used as a resource for any questions you may have with regard to the treatment of malaria.

For after-hours assistance please contact the infectious disease consultant on call at the respective center.

Canadian Malarial Network Coordinators

  National Program Coordinator National Pharmacy Coordinator

Name: 

Dr. Anne E. McCarthy  Kim Lamont, R. Ph. Tech.

Address: 

Director of Tropical Medicine and
International Health Clinic
Division of Infectious Diseases
Ottawa Hospital (General Campus)
501 Smyth Road, Ottawa, ON
K1H 8L6 
Pharmacy Department
Ottawa Hospital (General Campus)
501 Smyth Road Ottawa ON K1H 8L6

Phone #: 

(613) 737-8184   (613) 737-8899 ext. 72276

Fax #: 

(613) 737-8682   (613) 737-8891

E-Mail: 

amccarthy@ottawahospital.on.ca 

klamont@toh.on.ca

Canadian Malaria Network Centres, by province

British Columbia |Alberta |Saskatchewan |Manitoba |Ontario |Quebec |Nova Scotia |Newfoundland |

 
British Columbia

 

Designated Physician

Designated Pharmacist

Name: 

Dr. William Bowie

Dr. Tim Lau, Pharmacist et
Kaldip Mattu, Pharmacy technician

Address: 

Division of Infectious Diseases
Vancouver General Hospital
452D-2733 Heather Street Vancouver, BC  V5Z 3J5 

Pharmaceutical Sciences
Vancouver General Hospital
902 10th Avenue West
Vancouver, BC V5Z 1M9

Phone: 

(604) 875-4147 or (604) 875-4111 (ID physician on call) 

(604) 875-4111, ext. 63361 or
ext. 61571

Fax:

(604) 875-4013 

(604) 875-5267 

Email:

bowie@interchange.ubc.ca 

tim.lau@vch.ca or kaldip.mattu@vch.ca

Satellite Site

1. Vancouver Island Health Authority, Royal Jubilee Hospital, Tammy Larkin,
Phone: (250) 370-8673
2. Interior Health Authority, Kelowna General Hospital, Terry MacLeod,
Phone: (250) 491-6380

Alberta
  Designated Physician Designated Pharmacist
Name Dr. Stan Houston Wilson Cheng, Pharmacist
Address 2E4.12 WC Mackenzie Health         
Sciences Ctr.
University of Alberta
Edmonton, AB T6G 2B7
University of Alberta Hospital Pharmacy     
WMC OG1, 8440-112 Street
Edmonton, AB T6G 2B7
Phone (780) 407-8035 (780) 407-1586
Fax (780) 407-7137 (780) 407-8848
Email shouston@ualberta.ca wilson.cheng@albertahealthservices.ca
Satellite Site 1. Stanton Territorial Health Authority, Pharmacy, Cheryl Cooper
Phone: (867) 669-4165
Name Dr. Susan M. Kuhn Leah Boulter (Drug Information Pharmacist)
Address Alberta Children's Hospital                 
2888 Shaganappi Tr NW
Calgary, AB T3B 6A8
Alberta Children's Hospital
2888 Shaganappi Tr NW
Calgary, AB T3B 6A8
Phone (403) 955-7553 (403) 955-2999 (or 7204)
Fax (403) 955-3045 (403) 955-2719
Email susan.kuhn
@calgaryhealthregion.ca
leah.boulter@calgaryhealthregion.ca
Saskatchewan
  Designated Physician Designated Pharmacist
Name Dr. Karen McClean Christina Swiatecki, Pharmacist
Address Division of Infectious Diseases
Royal University Hospital
103 Hospital Drive
Saskatoon, SK S7N 0W8
Royal University Hospital Pharmacy
103 Hospital Drive
Saskatoon, SK S7N 0W8
Phone (604) 875-4147 or
(604) 875-4111
(ID Physician On Call)
(604) 875-4111 or
local 63361 or
local 61571
Fax (306) 655-1000
(hospital locating)
(306) 655-2279
Email karen.mcclean@usask.ca christina.swiatecki
@saskatoonhealthregion.ca
Satellite Site Regina
Manitoba
  Designated Physician Designated Pharmacist
Name Dr. Pierre Plourde, Medical Officer of Health Luke McKenzie, Pharmacist
Address Winnipeg Regional Health Authority
490 Hargrave Street
Winnipeg MB R3A 0X7
St-Boniface Gen. Hosp. Pharmacy     
409 Avenue Taché
Winnipeg MB R2H 2A6
Phone (204) 940-1683 or
(204) 237-2053
(ID on call Physician)
(204) 237- 2166
Fax (204) 956-4494 (204) 237-2165
Email pplourde@wrha.mb.ca lmckenzie@sbgh.mb.ca
Ontario
  Designated Physician Designated Pharmacist
Name Dr. Kevin C. Kain Tamara Rumsey, C. Ph. Tech.       
Address Toronto General Hospital                             
200 Elizabeth Street
Eaton North 13-214
Toronto ON M5G 2C4
Toronto General Hospital                      
University Health Network
200 Elizabeth Street. ENB-310
Toronto ON M5G 2C4
Phone (416) 340-3535 (416) 340-4800 ext. 3499
Fax (416) 595-5826 (416) 340-3685
Email kevin.kain@uhn.on.ca tamara.rumsey@uhn.on.ca
Name Dr. Anne E. McCarthy          Kim Lamont, R. Ph. Tech.
Address Director of Tropical Medicine and International Health Clinic
Division of Infectious Diseases Ottawa Hospital (General Campus)
501 Smyth Road      
Ottawa ON K1H 8L6
Pharmacy Department
Ottawa Hospital (General Campus)
501 Smyth Road
Ottawa ON K1H 8L6
Phone (613) 737-8184 (613) 737-8899 ext. 72276
Fax (604) 875-4013 (604) 875-5267
Email amccarthy@ottawahospital.on.ca klamont@toh.on.ca
Satellite Site 1. Ottawa Hospital (Civic Campus), Candace Teakles
Phone: (613)737-8899 ext.16642
2. Children's Hospital of Eastern Ontario (CHEO), Mary Malcomson
Phone: (613) 737-222
3. Kingston General Hospital, Susan McKenna,
Phone: (613) 549-6666 ext. 6286 (alternate: Chris Gray ext. 3654)
4. Hull Hospital (CSSS Gatineau), Alain Parenteau
Phone: (819) 595-6006
5. Thunder Bay Regional Health Science Centre, Jeff Chan
Phone: (807) 684-6327
6. North Bay General Hospital, Patti Euler
Phone: (705) 474-8600 ext. 2098
Name Dr. Shariq Haider Gita Sobhi, Pharmacist
Address Microbiology & Infectious Diseases
Room 3V51B
McMaster University Medical Centre
1200 Main Street West
Hamilton ON L6M 3Z8
McMaster University Pharmacy
1200 Main Street W
Hamilton ON L8S 4J9
Phone (905) 521-2100 ext. 26287
after hours: (905) 521-5030 pager 8020
(905) 521-2100 ext. 73447
Fax (905) 521-4971  
Email haider@univmail.cis.mcmaster.ca sobhi@hhsc.ca
Quebec
  Designated Physician Designated Pharmacist
Name Dr. Louise Côté Luc Bergeron, Msc, Pharmacist
Address Microbiology & Infectious Diseases
Centre hospitalier universitaire de Québec
Pavillon CHUL
2705, boul. Laurier, PL S-413
Sainte-Foy PQ G1V 4G2
Département de pharmacie
Centre hospitalier universitaire de Québec
Pavillon CHUL
2705, boul. Laurier, R-1720
Sainte-Foy PQ G1V 4G2
Phone (418) 656-4141 ext. 7882 (418) 656-4141 ext. 47916
Fax (418) 654-2147 (418) 654-2775
Email micro.pchul@chuq.ulaval.ca luc.bergeron@chuq.qc.ca
Name Dr. Brian Ward Denise Kalyvas, Pharmacist
Address The Montreal General Hospital
1650 Cedar Avenue
Room D7-153
Montreal PQ H3G 1A4
The Montreal General Hospital - Pharmacy
1650 Cedar Avenue
Room C1-200
Montreal PQ H3G 1A4
Phone (514) 921-6953 or
(514) 934-8075 (hospital locating)
(514) 934-1934 ext. 44933
Fax (514) 934-8347  
Email brian.ward@mcgill.ca denise.kalyvas@muhc.mcgill.ca
Satellite Site 1. Jewish General Hospital (Montreal), Caroline Robitaille
Phone: (514) 340-8222 ext 2825
2. Fleurimont Hospital (Sherbrooke), Sylvie Cloutier
Email: pharmaciecrc@chus.ssss.gouv.qc.ca
3. Amos

Nova Scotia
  Designated Physician Designated Pharmacist
Name Dr. David Haldane Patti Gallant, Pharmacy Research Technician     
Address Microbiology Laboratory
Mackenzie Building
VG Site, QE II HSC
5788 University Avenue
Halifax NS B1H 1V8
Pharmacy Department
Attn: Patti Gallant, Rm #2042
VG Site, QE II HSC
1276 South Park St.
Halifax NS B3H 2Y9
Phone (902) 473-6624 (902) 473-6601
Fax (902) 473-4432 (902) 473-1606
Email david.haldane@cdha.nshealth.ca patrice.gallant@cdha.nshealth.ca
Newfoundland
  Designated Physician Designated Pharmacist
Name Dr. Chau Nguyen Frank Pinsent, Pharmacist        
Address Division of Infectious Diseases, General Hospital
The Health Care Corporation
300 Prince Philip Drive
St. John's NL A1B 3V6
Department of Pharmacy
Health Science Centre
300 Prince Philip Drive
St. John's NL A1B 3V6
Phone (709) 777-8437                     (709) 777-6455
Fax (709) 777-7655 (709) 777-8120
Email eskinner@mun.ca hcc.pinf@hccsj.nf.ca